Compounded tirzepatide
Sold by NuBloom · every compounded tirzepatide record
The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.
What you actually pay
Per month
$279
| Medication · Starting price | $279 |
|---|
Added from the figures recorded below.
Price
| Term | Per month | Charged today |
|---|---|---|
| Starting price “Tirzepatide- Starting at $279/mo.” | Per month$279 | Charged today$279 |
We earn nothing from this link. NuBloom has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
History
One reading so far. A price history appears here after the next verification pass.
- September 2, 2026 — Entry added to the register
Sourcing and terms
| States | All states except Mississippi |
|---|---|
| Cancellation | “Order Cancellations Orders for non-prescription products may be canceled prior to shipment. Once an order has shipped, it is subject to the return policies outlined above. Prescription and compounded orders cannot be canceled once processing has begun.” |
Not yet checked: pharmacy, prescriber, membership and consult fee.
Recorded from mynubloom.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. September 2, 2026 — This is a genuine served-state LIST (a dedicated 'States Served' page), not an exclusion list, and it is worth flagging that it names 49 of the 50 states in standard alphabetical order — Mississippi is the one state conspicuously missing from an otherwise complete A-Z run. Recorded exactly as printed (49 states, no editorializing to '50' and no silent addition of the missing one). NuBloom explicitly states it deliberately does NOT prescribe GLP-1 in pill form as a clinical choice ('At NuBloom, GLP-1 treatment is offered as an injection rather than a pill... that is why we only offer GLP-1 injections'), so form is very likely a vial or pen, but the word 'vial' is never used, so per the brief's caution against inferring, form is left not-disclosed. Also offers a non-GLP-1 bupropion/naltrexone combo ($139/mo) and a 90-Day Guided Support Program pairing GLP-1 with coaching, neither entered as separate GLP-1 rows.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.